Bharat Parenterals
Easily search Stocks, Mutual Funds, eBooks, Articles and Videos
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Bharat Parenterals Limited functions as a pharmaceutical company, with its base in Vadodara, Gujarat. The organisation produces anti-retroviral drugs like pills, capsules, oral liquids, eye drops, lotion, creams, and injections for treating different disorders. Bharat Parenterals serves consumers in India and also has a huge client base internationally. Incorporated in 1992 by Mr Ramesh Desai, the company has set up a fully integrated and modern plant as per WHO standards. The company has their own research and development department. This stand-alone organisation comes with a vision of making world-class affordable medicines. Being exemplary in the field, BPL has accreditation and certifications from various health organisations across the world. They have clientele in 35 plus countries. At Bharat Parenterals Ltd, they engage in efficient analysis, growth, production, retailing, sourcing, and distribution of high-quality and best quality pharmaceutical products. As a completely integrated company, we have in-house R&D, business development, manufacturing and regulatory compliance capabilities.
The company deals in various pharmaceutical drugs and products. They also deal in Ayurvedic products. Bharat Parenterals Ltd has an expansive range of products and services, with over 800 products spread over more than 20 different categories. Some of the categories are-
B-LACTAM ANTIBIOTICS
ANTIRETROVIRAL
CEPHALOSPORINS ANTIBIOTICS
ANTIPROTOZOAL / ANTHELMINTIC
RESPIRATORY
ANTIALLERGIC / ANTI HISTAMINIC / ANTICOLD
CLEANSING AGENTS/SKIN INFECTIONS
ANTIBIOTIC
CARDIOVASCULAR SYSTEM
ANTIDIABETIC
ANTITUBERCULOSIS
ANTI FUNGAL
ANTIMALARIAL
GASTROINESTINALTRACT / ALIMENTARY SYSTEM
ANTIINFLAMMATORY / ANTI PYRETIC / ANALGESIC
SUPPLEMENTS
CENTRAL NERVOUS SYSTEM
ANAESTHETICS
ANTIVIRAL
STEROIDS AND HORMONES
UTERINE STIMULANT
ANTICANCER
Bharat Parenterals Ltd has developed and established its own state of art -Formulation & Development Department. It has been recognized by the Department of Scientific & Industrial Research (DSIR), New Delhi, in August-2010.
The company has a marketing tie-up with Panjon Ltd. Indore.
Dedicated to manufacturing an extensive spectrum of pharmaceutical formulation products, Bharat Parenterals Ltd hit a target of personnel strength of over 200 with a projected turnover of Rs.850 million in the fiscal year of 2012-13.
To expand their horizons, BPL participated in Arab Health 2018 held in Dubai, United Arab Emirates, from 29th January to 1st February 2018.
They also took part in iPHEX 2018 held at Pragati Maidan, Delhi, from 8th to 10th May 2018.
Presenting in CPHI Worldwide, 2018 held at IFEMA - Feria de Madrid, Spain during 9th to 12th October 2018.
They also exhibited in CPHI Worldwide 2019, held in Frankfurt, Germany, from 5th to 7th November 2019.
Bharat Parenterals Ltd received the license and authorisation from the Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO), New Delhi, for the manufacturing and marketing of Favipiravir Oral Suspension l00mg/ml, which is used for the treatment of Covid-19 disease.
They were honoured with Rashtriya Udyog Ratan Award by the Economic Growth Society of India for outstanding contribution & Lifetime achievement in the respective field.
BPL was awarded India's best SME 100 Awards by Axis Bank 2017.
Awarded for Excellence - Certificate of Merit for Outstanding MSME, 2018 by Federation of Gujarat Industries,
Exim Club Awards 2018 – New Export Product Development of the Year 2017-18.
Invest Yadnya is an eLearning platform engaged in educating & simplifying the contents based on personal finance for all individuals. We have combined technology with financial planning expertise to assist an individual in meeting their financial objectives. We provide valuable time, money, and knowledge to create India’s financial literacy with Bharat Parenterals Ltd fundamental analysis.
Invest Yadnya provides an unbiased & transparent Bharat Parenterals Ltd share analysis. We keep on updating our data & supply the latest information. Our main objective is to assist our clients in research on 950+ companies, including Bharat Parenterals Ltd stock analysis.
We also provide our clients with the Bharat Parenterals Ltd annual report to understand its financial position before making any investment decisions. Bharat Parenterals Ltd balance sheet offers a summary of how the company incurs revenues & expenses.
You will get to know the ratio analysis, cash flows, income and expenses, and the company's historical growth rate. Bharat Parenterals Ltd results help the clients understand its financial position before making any investment decisions. The investors are also able to identify the core values and worth of the company. We also provide the quarterly results of the company so that you get a clear idea. Invest confidently and in a secured manner at Invest Yadnya. Create a free account and search for all the details about Bharat Parenterals before making your investment.
We help our clients do extensive research on 950+ companies, including Bharat Parenterals share review.
We also provide our clients with the Bharat Parenterals Ltd share price graph. It helps the clients understand the financial position of the company before making any investment decisions. The Bharat Parenterals results help the investors identify the intrinsic worth of the security. The Bharat Parenterals financial analysis provides a summary of how the business incurs revenues and expenses.
Invest Yadnya offers numerous resources for Bharat Parenterals fundamental analysis. With the available Bharat Parenterals stock price, annual report, price chart, ratios, etc., get a detailed analysis of the company. With Invest Yadnya’s available resources, get an overview of the company, both from the qualitative and financial perspectives. The investors shall make a viable investment decision depending on their risk profile & other economic factors.
The Bharat Parenterals Ltd research report gives the clients a better understanding of the company’s EPS, Debt-Equity Ratio, etc. It helps clients take the first step in choosing which companies to invest in.
The Bharat Parenterals quarterly results & Bharat Parenterals financial statements help allocate the equity in the Portfolio of an investor to add to its favourable returns.
To find the Bharat Parenterals performance analysis & Bharat Parenterals share price, subscribe to our Equity Research and Stock Fundamental Analysis Tool, Stock-O-Meter.
Our website has information about 113 other Pharmaceuticals & Drugs companies that give insight into its financials. Companies include Divis Laboratories, Dr Reddys Laboratories, Cipla, Biocon, Aurobindo Pharma, Lupin, Torrent Pharmaceuticals, Cadila Healthcare, Abbott India, Glaxosmithkline Pharmaceuticals & many more.
Comment